z-logo
open-access-imgOpen Access
ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer
Author(s) -
О. П. Колеснік,
V. A. Kuz’menko
Publication year - 2020
Publication title -
pathologia
Language(s) - English
Resource type - Journals
eISSN - 2310-1237
pISSN - 2306-8027
DOI - 10.14739/2310-1237.2020.1.203639
Subject(s) - ercc1 , lung cancer , medicine , oncology , chemotherapy , stage (stratigraphy) , clinical significance , immunohistochemistry , biology , paleontology , biochemistry , nucleotide excision repair , dna repair , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom